nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—type 2 diabetes mellitus	0.252	1	CbGaD
Nepafenac—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.197	1	CrCrCtD
Nepafenac—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.092	0.227	CbGbCtD
Nepafenac—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.092	0.227	CbGbCtD
Nepafenac—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0849	0.209	CbGbCtD
Nepafenac—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0697	0.172	CbGbCtD
Nepafenac—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0668	0.165	CbGbCtD
Nepafenac—Ocular discomfort—Bromocriptine—type 2 diabetes mellitus	0.0037	0.0438	CcSEcCtD
Nepafenac—Visual acuity reduced—Rosiglitazone—type 2 diabetes mellitus	0.00192	0.0227	CcSEcCtD
Nepafenac—PTGS2—leg—type 2 diabetes mellitus	0.00184	0.177	CbGeAlD
Nepafenac—Pregnancy—Pioglitazone—type 2 diabetes mellitus	0.00169	0.02	CcSEcCtD
Nepafenac—PTGS2—hindlimb—type 2 diabetes mellitus	0.00164	0.158	CbGeAlD
Nepafenac—Visual acuity reduced—Pioglitazone—type 2 diabetes mellitus	0.00161	0.019	CcSEcCtD
Nepafenac—Diabetes mellitus—Linagliptin—type 2 diabetes mellitus	0.00124	0.0147	CcSEcCtD
Nepafenac—Dermatitis atopic—Bromocriptine—type 2 diabetes mellitus	0.00114	0.0134	CcSEcCtD
Nepafenac—PTGS1—artery—type 2 diabetes mellitus	0.00105	0.102	CbGeAlD
Nepafenac—PTGS2—artery—type 2 diabetes mellitus	0.00101	0.0971	CbGeAlD
Nepafenac—Diabetes mellitus—Rosiglitazone—type 2 diabetes mellitus	0.000952	0.0113	CcSEcCtD
Nepafenac—PTGS1—endothelium—type 2 diabetes mellitus	0.000889	0.0858	CbGeAlD
Nepafenac—PTGS2—endothelium—type 2 diabetes mellitus	0.000849	0.082	CbGeAlD
Nepafenac—Diabetes mellitus—Pioglitazone—type 2 diabetes mellitus	0.000798	0.00945	CcSEcCtD
Nepafenac—Diabetes mellitus—Glimepiride—type 2 diabetes mellitus	0.000778	0.00921	CcSEcCtD
Nepafenac—Cataract—Gliclazide—type 2 diabetes mellitus	0.000725	0.00858	CcSEcCtD
Nepafenac—Diabetes mellitus—Bromocriptine—type 2 diabetes mellitus	0.000701	0.00831	CcSEcCtD
Nepafenac—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.00069	0.00817	CcSEcCtD
Nepafenac—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.000676	0.008	CcSEcCtD
Nepafenac—Angiopathy—Acarbose—type 2 diabetes mellitus	0.000659	0.0078	CcSEcCtD
Nepafenac—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.000656	0.00776	CcSEcCtD
Nepafenac—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.000634	0.00751	CcSEcCtD
Nepafenac—Sinusitis—Repaglinide—type 2 diabetes mellitus	0.000633	0.0075	CcSEcCtD
Nepafenac—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.000632	0.00749	CcSEcCtD
Nepafenac—Sinusitis—Rosiglitazone—type 2 diabetes mellitus	0.000599	0.00709	CcSEcCtD
Nepafenac—Arthritis—Glyburide—type 2 diabetes mellitus	0.000574	0.00679	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000567	0.00671	CcSEcCtD
Nepafenac—Eye disorder—Repaglinide—type 2 diabetes mellitus	0.000566	0.00671	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00055	0.00652	CcSEcCtD
Nepafenac—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.000547	0.00648	CcSEcCtD
Nepafenac—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.000545	0.00645	CcSEcCtD
Nepafenac—Cataract—Losartan—type 2 diabetes mellitus	0.000539	0.00638	CcSEcCtD
Nepafenac—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.000535	0.00634	CcSEcCtD
Nepafenac—Diabetes mellitus—Orlistat—type 2 diabetes mellitus	0.000523	0.00619	CcSEcCtD
Nepafenac—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000517	0.00613	CcSEcCtD
Nepafenac—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.000516	0.00611	CcSEcCtD
Nepafenac—Arthritis—Gliclazide—type 2 diabetes mellitus	0.000515	0.0061	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.000509	0.00603	CcSEcCtD
Nepafenac—Sinusitis—Pioglitazone—type 2 diabetes mellitus	0.000502	0.00594	CcSEcCtD
Nepafenac—Sinusitis—Sitagliptin—type 2 diabetes mellitus	0.000487	0.00577	CcSEcCtD
Nepafenac—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000483	0.0467	CbGeAlD
Nepafenac—Eye disorder—Glipizide—type 2 diabetes mellitus	0.000469	0.00555	CcSEcCtD
Nepafenac—Arthritis—Orlistat—type 2 diabetes mellitus	0.000468	0.00554	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.000464	0.00549	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.000464	0.00549	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000459	0.00543	CcSEcCtD
Nepafenac—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000455	0.00539	CcSEcCtD
Nepafenac—Diabetes mellitus—Irbesartan—type 2 diabetes mellitus	0.000455	0.00538	CcSEcCtD
Nepafenac—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.000449	0.00531	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.000446	0.00528	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.000445	0.00527	CcSEcCtD
Nepafenac—Sinusitis—Bromocriptine—type 2 diabetes mellitus	0.000441	0.00522	CcSEcCtD
Nepafenac—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.000436	0.00516	CcSEcCtD
Nepafenac—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.000434	0.00514	CcSEcCtD
Nepafenac—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.00043	0.0051	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000429	0.00508	CcSEcCtD
Nepafenac—Diabetes mellitus—Losartan—type 2 diabetes mellitus	0.000428	0.00507	CcSEcCtD
Nepafenac—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.000423	0.00501	CcSEcCtD
Nepafenac—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.000421	0.00499	CcSEcCtD
Nepafenac—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000418	0.00495	CcSEcCtD
Nepafenac—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000418	0.00494	CcSEcCtD
Nepafenac—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000411	0.00487	CcSEcCtD
Nepafenac—Arthritis—Irbesartan—type 2 diabetes mellitus	0.000407	0.00482	CcSEcCtD
Nepafenac—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000399	0.00472	CcSEcCtD
Nepafenac—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.000394	0.00467	CcSEcCtD
Nepafenac—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000391	0.00464	CcSEcCtD
Nepafenac—Nausea—Miglitol—type 2 diabetes mellitus	0.00039	0.00462	CcSEcCtD
Nepafenac—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000384	0.00454	CcSEcCtD
Nepafenac—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.000383	0.00453	CcSEcCtD
Nepafenac—Arthritis—Losartan—type 2 diabetes mellitus	0.000383	0.00453	CcSEcCtD
Nepafenac—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000383	0.00453	CcSEcCtD
Nepafenac—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00038	0.0045	CcSEcCtD
Nepafenac—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00038	0.0045	CcSEcCtD
Nepafenac—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00038	0.0045	CcSEcCtD
Nepafenac—Hypertension—Glipizide—type 2 diabetes mellitus	0.000377	0.00446	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000372	0.0044	CcSEcCtD
Nepafenac—Headache—Tolbutamide—type 2 diabetes mellitus	0.00037	0.00438	CcSEcCtD
Nepafenac—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000366	0.00434	CcSEcCtD
Nepafenac—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000366	0.0353	CbGeAlD
Nepafenac—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.000362	0.00429	CcSEcCtD
Nepafenac—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000361	0.00427	CcSEcCtD
Nepafenac—Eye disorder—Glyburide—type 2 diabetes mellitus	0.000361	0.00427	CcSEcCtD
Nepafenac—PTGS1—kidney—type 2 diabetes mellitus	0.000358	0.0345	CbGeAlD
Nepafenac—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000355	0.0042	CcSEcCtD
Nepafenac—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000355	0.0042	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000353	0.00419	CcSEcCtD
Nepafenac—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000352	0.00417	CcSEcCtD
Nepafenac—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000352	0.00416	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000351	0.00416	CcSEcCtD
Nepafenac—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000351	0.00415	CcSEcCtD
Nepafenac—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00415	CcSEcCtD
Nepafenac—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000349	0.0337	CbGeAlD
Nepafenac—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000346	0.0041	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000343	0.00406	CcSEcCtD
Nepafenac—PTGS2—kidney—type 2 diabetes mellitus	0.000342	0.033	CbGeAlD
Nepafenac—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000341	0.00404	CcSEcCtD
Nepafenac—PTGS2—pancreas—type 2 diabetes mellitus	0.00034	0.0328	CbGeAlD
Nepafenac—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000339	0.00402	CcSEcCtD
Nepafenac—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000338	0.004	CcSEcCtD
Nepafenac—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000336	0.00398	CcSEcCtD
Nepafenac—Headache—Tolazamide—type 2 diabetes mellitus	0.000336	0.00398	CcSEcCtD
Nepafenac—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000335	0.00396	CcSEcCtD
Nepafenac—Headache—Linagliptin—type 2 diabetes mellitus	0.000333	0.00394	CcSEcCtD
Nepafenac—Sinusitis—Valsartan—type 2 diabetes mellitus	0.000333	0.00394	CcSEcCtD
Nepafenac—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000331	0.00392	CcSEcCtD
Nepafenac—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000329	0.00389	CcSEcCtD
Nepafenac—Sinusitis—Orlistat—type 2 diabetes mellitus	0.000329	0.00389	CcSEcCtD
Nepafenac—Arthritis—Ramipril—type 2 diabetes mellitus	0.000328	0.00389	CcSEcCtD
Nepafenac—Vomiting—Acarbose—type 2 diabetes mellitus	0.000328	0.00388	CcSEcCtD
Nepafenac—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000325	0.00385	CcSEcCtD
Nepafenac—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000324	0.00383	CcSEcCtD
Nepafenac—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000322	0.0311	CbGeAlD
Nepafenac—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000322	0.00381	CcSEcCtD
Nepafenac—Nausea—Tolazamide—type 2 diabetes mellitus	0.000319	0.00378	CcSEcCtD
Nepafenac—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000319	0.00378	CcSEcCtD
Nepafenac—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00376	CcSEcCtD
Nepafenac—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000317	0.00376	CcSEcCtD
Nepafenac—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000317	0.00375	CcSEcCtD
Nepafenac—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000316	0.00374	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000311	0.00368	CcSEcCtD
Nepafenac—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000308	0.0298	CbGeAlD
Nepafenac—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000308	0.00364	CcSEcCtD
Nepafenac—Nausea—Acarbose—type 2 diabetes mellitus	0.000306	0.00363	CcSEcCtD
Nepafenac—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00362	CcSEcCtD
Nepafenac—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000305	0.00361	CcSEcCtD
Nepafenac—Nausea—Nateglinide—type 2 diabetes mellitus	0.000295	0.0035	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000295	0.00349	CcSEcCtD
Nepafenac—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000294	0.00348	CcSEcCtD
Nepafenac—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000291	0.00345	CcSEcCtD
Nepafenac—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000289	0.00342	CcSEcCtD
Nepafenac—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000288	0.00341	CcSEcCtD
Nepafenac—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000288	0.0034	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000287	0.0034	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000286	0.00339	CcSEcCtD
Nepafenac—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000284	0.00336	CcSEcCtD
Nepafenac—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000274	0.00324	CcSEcCtD
Nepafenac—Eye disorder—Metformin—type 2 diabetes mellitus	0.000271	0.00321	CcSEcCtD
Nepafenac—Headache—Repaglinide—type 2 diabetes mellitus	0.00027	0.00319	CcSEcCtD
Nepafenac—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00319	CcSEcCtD
Nepafenac—Sinusitis—Losartan—type 2 diabetes mellitus	0.000269	0.00319	CcSEcCtD
Nepafenac—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000269	0.00318	CcSEcCtD
Nepafenac—Angiopathy—Metformin—type 2 diabetes mellitus	0.000263	0.00311	CcSEcCtD
Nepafenac—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000262	0.00311	CcSEcCtD
Nepafenac—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000262	0.0031	CcSEcCtD
Nepafenac—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000261	0.00309	CcSEcCtD
Nepafenac—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00026	0.00308	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00307	CcSEcCtD
Nepafenac—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000258	0.00306	CcSEcCtD
Nepafenac—Nausea—Repaglinide—type 2 diabetes mellitus	0.000256	0.00303	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000255	0.00302	CcSEcCtD
Nepafenac—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000255	0.00302	CcSEcCtD
Nepafenac—Pruritus—Glipizide—type 2 diabetes mellitus	0.000252	0.00298	CcSEcCtD
Nepafenac—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000251	0.00298	CcSEcCtD
Nepafenac—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000251	0.00297	CcSEcCtD
Nepafenac—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000248	0.00294	CcSEcCtD
Nepafenac—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000247	0.00293	CcSEcCtD
Nepafenac—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000245	0.0029	CcSEcCtD
Nepafenac—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00289	CcSEcCtD
Nepafenac—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000242	0.00286	CcSEcCtD
Nepafenac—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000241	0.00286	CcSEcCtD
Nepafenac—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000239	0.00283	CcSEcCtD
Nepafenac—Vision blurred—Metformin—type 2 diabetes mellitus	0.000238	0.00282	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000237	0.0028	CcSEcCtD
Nepafenac—Dizziness—Glipizide—type 2 diabetes mellitus	0.000236	0.00279	CcSEcCtD
Nepafenac—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000235	0.00278	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000234	0.00277	CcSEcCtD
Nepafenac—Angiopathy—Losartan—type 2 diabetes mellitus	0.000234	0.00277	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000231	0.00274	CcSEcCtD
Nepafenac—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000231	0.00273	CcSEcCtD
Nepafenac—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000231	0.00273	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—type 2 diabetes mellitus	0.00023	0.0726	CrCbGaD
Nepafenac—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000228	0.0027	CcSEcCtD
Nepafenac—Vomiting—Glipizide—type 2 diabetes mellitus	0.000226	0.00268	CcSEcCtD
Nepafenac—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000226	0.00267	CcSEcCtD
Nepafenac—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000224	0.00266	CcSEcCtD
Nepafenac—Headache—Glipizide—type 2 diabetes mellitus	0.000223	0.00264	CcSEcCtD
Nepafenac—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000222	0.00263	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—type 2 diabetes mellitus	0.000221	0.0696	CrCbGaD
Nepafenac—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00022	0.0026	CcSEcCtD
Nepafenac—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00022	0.0026	CcSEcCtD
Nepafenac—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000219	0.00259	CcSEcCtD
Nepafenac—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00259	CcSEcCtD
Nepafenac—Hypertension—Metformin—type 2 diabetes mellitus	0.000218	0.00258	CcSEcCtD
Nepafenac—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000217	0.00257	CcSEcCtD
Nepafenac—PTGS2—liver—type 2 diabetes mellitus	0.000216	0.0209	CbGeAlD
Nepafenac—Headache—Pioglitazone—type 2 diabetes mellitus	0.000214	0.00253	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000213	0.00253	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000213	0.00252	CcSEcCtD
Nepafenac—Nausea—Glipizide—type 2 diabetes mellitus	0.000212	0.00251	CcSEcCtD
Nepafenac—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000211	0.0025	CcSEcCtD
Nepafenac—Vision blurred—Losartan—type 2 diabetes mellitus	0.000211	0.0025	CcSEcCtD
Nepafenac—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00249	CcSEcCtD
Nepafenac—Headache—Glimepiride—type 2 diabetes mellitus	0.000208	0.00247	CcSEcCtD
Nepafenac—Headache—Sitagliptin—type 2 diabetes mellitus	0.000208	0.00246	CcSEcCtD
Nepafenac—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000206	0.00243	CcSEcCtD
Nepafenac—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000202	0.00239	CcSEcCtD
Nepafenac—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000202	0.00239	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000201	0.00238	CcSEcCtD
Nepafenac—Skin disorder—Metformin—type 2 diabetes mellitus	0.0002	0.00237	CcSEcCtD
Nepafenac—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000199	0.00236	CcSEcCtD
Nepafenac—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00235	CcSEcCtD
Nepafenac—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000198	0.00235	CcSEcCtD
Nepafenac—Nausea—Glimepiride—type 2 diabetes mellitus	0.000197	0.00234	CcSEcCtD
Nepafenac—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00233	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000195	0.00231	CcSEcCtD
Nepafenac—Pruritus—Glyburide—type 2 diabetes mellitus	0.000194	0.0023	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000193	0.00228	CcSEcCtD
Nepafenac—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00226	CcSEcCtD
Nepafenac—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000191	0.00226	CcSEcCtD
Nepafenac—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000189	0.00224	CcSEcCtD
Nepafenac—Headache—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00222	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—type 2 diabetes mellitus	0.000188	0.0592	CrCbGaD
Nepafenac—Dry mouth—Losartan—type 2 diabetes mellitus	0.000187	0.00221	CcSEcCtD
Nepafenac—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000181	0.00215	CcSEcCtD
Nepafenac—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000179	0.00212	CcSEcCtD
Nepafenac—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00211	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000178	0.00211	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—type 2 diabetes mellitus	0.000175	0.055	CrCbGaD
Nepafenac—Vomiting—Glyburide—type 2 diabetes mellitus	0.000174	0.00206	CcSEcCtD
Nepafenac—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000174	0.00206	CcSEcCtD
Nepafenac—Headache—Glyburide—type 2 diabetes mellitus	0.000172	0.00203	CcSEcCtD
Nepafenac—Mebendazole—CYP3A4—type 2 diabetes mellitus	0.000171	0.0539	CrCbGaD
Nepafenac—Fenbufen—PTGS2—type 2 diabetes mellitus	0.000171	0.0538	CrCbGaD
Nepafenac—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000168	0.00199	CcSEcCtD
Nepafenac—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000167	0.00197	CcSEcCtD
Nepafenac—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000165	0.00195	CcSEcCtD
Nepafenac—Nausea—Glyburide—type 2 diabetes mellitus	0.000163	0.00193	CcSEcCtD
Nepafenac—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000163	0.00193	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000162	0.00192	CcSEcCtD
Nepafenac—Carbamazepine—ABCC2—type 2 diabetes mellitus	0.000162	0.0511	CrCbGaD
Nepafenac—Pruritus—Valsartan—type 2 diabetes mellitus	0.00016	0.00189	CcSEcCtD
Nepafenac—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00016	0.00189	CcSEcCtD
Nepafenac—Pruritus—Orlistat—type 2 diabetes mellitus	0.000158	0.00187	CcSEcCtD
Nepafenac—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—type 2 diabetes mellitus	0.000156	0.049	CrCbGaD
Nepafenac—Headache—Gliclazide—type 2 diabetes mellitus	0.000154	0.00183	CcSEcCtD
Nepafenac—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.00182	CcSEcCtD
Nepafenac—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000152	0.0018	CcSEcCtD
Nepafenac—Dizziness—Valsartan—type 2 diabetes mellitus	0.00015	0.00177	CcSEcCtD
Nepafenac—Salsalate—PTGS2—type 2 diabetes mellitus	0.000148	0.0468	CrCbGaD
Nepafenac—Dizziness—Orlistat—type 2 diabetes mellitus	0.000148	0.00175	CcSEcCtD
Nepafenac—Nausea—Gliclazide—type 2 diabetes mellitus	0.000146	0.00173	CcSEcCtD
Nepafenac—Pruritus—Metformin—type 2 diabetes mellitus	0.000146	0.00173	CcSEcCtD
Nepafenac—Vomiting—Valsartan—type 2 diabetes mellitus	0.000144	0.0017	CcSEcCtD
Nepafenac—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000143	0.0017	CcSEcCtD
Nepafenac—Vomiting—Orlistat—type 2 diabetes mellitus	0.000142	0.00168	CcSEcCtD
Nepafenac—Headache—Valsartan—type 2 diabetes mellitus	0.000142	0.00168	CcSEcCtD
Nepafenac—Headache—Orlistat—type 2 diabetes mellitus	0.00014	0.00166	CcSEcCtD
Nepafenac—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000137	0.00163	CcSEcCtD
Nepafenac—Dizziness—Metformin—type 2 diabetes mellitus	0.000136	0.00161	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.0016	CcSEcCtD
Nepafenac—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000135	0.0016	CcSEcCtD
Nepafenac—Nausea—Valsartan—type 2 diabetes mellitus	0.000134	0.00159	CcSEcCtD
Nepafenac—Nausea—Orlistat—type 2 diabetes mellitus	0.000133	0.00157	CcSEcCtD
Nepafenac—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000133	0.0418	CrCbGaD
Nepafenac—Vomiting—Metformin—type 2 diabetes mellitus	0.000131	0.00155	CcSEcCtD
Nepafenac—Pruritus—Losartan—type 2 diabetes mellitus	0.000129	0.00153	CcSEcCtD
Nepafenac—Headache—Metformin—type 2 diabetes mellitus	0.000129	0.00153	CcSEcCtD
Nepafenac—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000129	0.00152	CcSEcCtD
Nepafenac—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000126	0.0397	CrCbGaD
Nepafenac—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000124	0.00146	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—type 2 diabetes mellitus	0.000123	0.0386	CrCbGaD
Nepafenac—Nausea—Metformin—type 2 diabetes mellitus	0.000122	0.00145	CcSEcCtD
Nepafenac—Headache—Irbesartan—type 2 diabetes mellitus	0.000122	0.00144	CcSEcCtD
Nepafenac—Dizziness—Losartan—type 2 diabetes mellitus	0.000121	0.00143	CcSEcCtD
Nepafenac—Modafinil—CYP1A2—type 2 diabetes mellitus	0.000119	0.0374	CrCbGaD
Nepafenac—Vomiting—Losartan—type 2 diabetes mellitus	0.000116	0.00138	CcSEcCtD
Nepafenac—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000116	0.00137	CcSEcCtD
Nepafenac—Nausea—Irbesartan—type 2 diabetes mellitus	0.000115	0.00137	CcSEcCtD
Nepafenac—Headache—Losartan—type 2 diabetes mellitus	0.000115	0.00136	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—type 2 diabetes mellitus	0.000114	0.0358	CrCbGaD
Nepafenac—Pruritus—Ramipril—type 2 diabetes mellitus	0.000111	0.00131	CcSEcCtD
Nepafenac—Fenoprofen—ALB—type 2 diabetes mellitus	0.000109	0.0344	CrCbGaD
Nepafenac—Nausea—Losartan—type 2 diabetes mellitus	0.000109	0.00129	CcSEcCtD
Nepafenac—Carbamazepine—CYP1A2—type 2 diabetes mellitus	0.000108	0.0341	CrCbGaD
Nepafenac—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	0.000105	0.0331	CrCbGaD
Nepafenac—Dizziness—Ramipril—type 2 diabetes mellitus	0.000104	0.00123	CcSEcCtD
Nepafenac—Vomiting—Ramipril—type 2 diabetes mellitus	9.97e-05	0.00118	CcSEcCtD
Nepafenac—Headache—Ramipril—type 2 diabetes mellitus	9.82e-05	0.00116	CcSEcCtD
Nepafenac—Nausea—Ramipril—type 2 diabetes mellitus	9.32e-05	0.0011	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—type 2 diabetes mellitus	9.17e-05	0.0289	CrCbGaD
Nepafenac—Diclofenac—CYP3A4—type 2 diabetes mellitus	8.35e-05	0.0263	CrCbGaD
Nepafenac—Diclofenac—PTGS2—type 2 diabetes mellitus	8.17e-05	0.0258	CrCbGaD
Nepafenac—Modafinil—CYP3A4—type 2 diabetes mellitus	7.85e-05	0.0247	CrCbGaD
Nepafenac—Diclofenac—ALB—type 2 diabetes mellitus	7.28e-05	0.0229	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—type 2 diabetes mellitus	7.24e-05	0.0228	CrCbGaD
Nepafenac—Carbamazepine—CYP3A4—type 2 diabetes mellitus	7.16e-05	0.0226	CrCbGaD
Nepafenac—Ketoprofen—ALB—type 2 diabetes mellitus	6.45e-05	0.0203	CrCbGaD
Nepafenac—PTGS1—Metabolism—GCGR—type 2 diabetes mellitus	4.07e-05	0.000844	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.04e-05	0.000837	CbGpPWpGaD
Nepafenac—PTGS2—Disease—G6PC—type 2 diabetes mellitus	3.99e-05	0.000826	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ENPP1—type 2 diabetes mellitus	3.99e-05	0.000826	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP1R3C—type 2 diabetes mellitus	3.99e-05	0.000826	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	3.95e-05	0.000818	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	3.94e-05	0.000816	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CDO1—type 2 diabetes mellitus	3.93e-05	0.000813	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPD2—type 2 diabetes mellitus	3.93e-05	0.000813	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.92e-05	0.000812	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	3.88e-05	0.000805	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYTB—type 2 diabetes mellitus	3.85e-05	0.000797	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—OXCT1—type 2 diabetes mellitus	3.85e-05	0.000797	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.84e-05	0.000795	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.81e-05	0.00079	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.75e-05	0.000776	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AK1—type 2 diabetes mellitus	3.75e-05	0.000776	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.7e-05	0.000767	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.58e-05	0.000741	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STAR—type 2 diabetes mellitus	3.58e-05	0.000741	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACACA—type 2 diabetes mellitus	3.58e-05	0.000741	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MAT1A—type 2 diabetes mellitus	3.46e-05	0.000716	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC5A4—type 2 diabetes mellitus	3.46e-05	0.000716	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.44e-05	0.000713	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCC8—type 2 diabetes mellitus	3.43e-05	0.00071	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CBS—type 2 diabetes mellitus	3.43e-05	0.00071	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	3.42e-05	0.000709	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.39e-05	0.000702	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ACACA—type 2 diabetes mellitus	3.39e-05	0.000702	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.38e-05	0.0007	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	3.36e-05	0.000695	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.35e-05	0.000693	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ND1—type 2 diabetes mellitus	3.34e-05	0.000691	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—G6PC—type 2 diabetes mellitus	3.34e-05	0.000691	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HBA2—type 2 diabetes mellitus	3.34e-05	0.000691	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.34e-05	0.000691	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ENPP1—type 2 diabetes mellitus	3.34e-05	0.000691	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.3e-05	0.000683	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COX2—type 2 diabetes mellitus	3.3e-05	0.000683	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.26e-05	0.000676	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOA6—type 2 diabetes mellitus	3.24e-05	0.000671	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.24e-05	0.000671	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCGR—type 2 diabetes mellitus	3.23e-05	0.00067	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—type 2 diabetes mellitus	3.2e-05	0.000662	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.19e-05	0.00066	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UCP2—type 2 diabetes mellitus	3.19e-05	0.00066	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UCP3—type 2 diabetes mellitus	3.19e-05	0.00066	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC5A2—type 2 diabetes mellitus	3.13e-05	0.000648	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.11e-05	0.000645	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.09e-05	0.00064	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—OXCT1—type 2 diabetes mellitus	3.05e-05	0.000632	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYTB—type 2 diabetes mellitus	3.05e-05	0.000632	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PCK1—type 2 diabetes mellitus	3e-05	0.000621	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.99e-05	0.000619	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	2.98e-05	0.000616	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.95e-05	0.000611	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.88e-05	0.000596	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PCK1—type 2 diabetes mellitus	2.84e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	2.84e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	2.84e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	2.84e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HK1—type 2 diabetes mellitus	2.81e-05	0.000581	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.8e-05	0.000581	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.8e-05	0.000579	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TLE4—type 2 diabetes mellitus	2.76e-05	0.000572	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	2.72e-05	0.000564	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	2.72e-05	0.000564	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.71e-05	0.000561	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPA—type 2 diabetes mellitus	2.71e-05	0.000561	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.71e-05	0.000561	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCKR—type 2 diabetes mellitus	2.71e-05	0.000561	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HK1—type 2 diabetes mellitus	2.66e-05	0.000551	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	2.62e-05	0.000543	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	2.62e-05	0.000543	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.61e-05	0.00054	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.6e-05	0.00054	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDOB—type 2 diabetes mellitus	2.6e-05	0.000538	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	2.58e-05	0.000534	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	2.57e-05	0.000533	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.57e-05	0.000533	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCKR—type 2 diabetes mellitus	2.57e-05	0.000532	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.54e-05	0.000525	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	2.53e-05	0.000524	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	2.53e-05	0.000524	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.53e-05	0.000524	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.52e-05	0.000523	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.47e-05	0.000512	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	2.46e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.45e-05	0.000508	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.44e-05	0.000506	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GLP1R—type 2 diabetes mellitus	2.42e-05	0.0005	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	2.38e-05	0.000493	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	2.35e-05	0.000487	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.34e-05	0.000485	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.33e-05	0.000482	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP4—type 2 diabetes mellitus	2.29e-05	0.000474	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.28e-05	0.000473	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.28e-05	0.000473	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.25e-05	0.000467	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	2.23e-05	0.000461	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.22e-05	0.000461	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	2.21e-05	0.000458	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	2.21e-05	0.000458	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.17e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	2.17e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.15e-05	0.000446	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.14e-05	0.000443	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	2.14e-05	0.000443	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.1e-05	0.000435	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTR—type 2 diabetes mellitus	2.09e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	2.08e-05	0.00043	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.07e-05	0.000428	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	2.06e-05	0.000427	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	2.05e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCK—type 2 diabetes mellitus	2.04e-05	0.000423	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IAPP—type 2 diabetes mellitus	2.03e-05	0.00042	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2e-05	0.000415	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.99e-05	0.000413	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.96e-05	0.000407	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.94e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.94e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.93e-05	0.0004	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.93e-05	0.0004	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.93e-05	0.0004	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.92e-05	0.000397	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.9e-05	0.000393	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.88e-05	0.000389	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.87e-05	0.000387	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.85e-05	0.000384	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.84e-05	0.000381	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.83e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.83e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.79e-05	0.000371	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.77e-05	0.000367	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.77e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.75e-05	0.000363	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.75e-05	0.000363	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.75e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.75e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.72e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.71e-05	0.000355	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.71e-05	0.000354	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.71e-05	0.000354	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.71e-05	0.000354	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.71e-05	0.000354	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.7e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.7e-05	0.000352	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.69e-05	0.000351	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.67e-05	0.000347	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.67e-05	0.000347	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.67e-05	0.000345	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.66e-05	0.000343	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.65e-05	0.000342	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.63e-05	0.000338	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.62e-05	0.000335	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.61e-05	0.000334	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.59e-05	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.54e-05	0.000318	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.53e-05	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.53e-05	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.53e-05	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.5e-05	0.000312	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.49e-05	0.000309	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.47e-05	0.000305	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.46e-05	0.000302	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	1.44e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.44e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	1.44e-05	0.000298	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	1.42e-05	0.000294	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.4e-05	0.00029	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.39e-05	0.000287	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.39e-05	0.000287	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	1.38e-05	0.000286	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	1.38e-05	0.000285	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.35e-05	0.00028	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	1.34e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	1.34e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.33e-05	0.000275	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	1.33e-05	0.000275	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	1.31e-05	0.000272	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOB—type 2 diabetes mellitus	1.3e-05	0.00027	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	1.29e-05	0.000266	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	1.28e-05	0.000265	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	1.25e-05	0.000259	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—type 2 diabetes mellitus	1.25e-05	0.000258	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-05	0.000255	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	1.22e-05	0.000253	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-05	0.000245	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	1.17e-05	0.000242	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—type 2 diabetes mellitus	1.15e-05	0.000238	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.15e-05	0.000237	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	1.15e-05	0.000237	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	1.14e-05	0.000236	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	1.12e-05	0.000233	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	1.12e-05	0.000233	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	1.12e-05	0.000232	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-05	0.000229	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.1e-05	0.000228	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.09e-05	0.000226	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-05	0.000225	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.07e-05	0.000221	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.07e-05	0.000221	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.06e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.05e-05	0.000217	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.04e-05	0.000216	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.04e-05	0.000216	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.03e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000211	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.02e-05	0.000211	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	9.91e-06	0.000205	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.78e-06	0.000203	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—type 2 diabetes mellitus	9.73e-06	0.000201	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	9.59e-06	0.000199	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INS—type 2 diabetes mellitus	9.41e-06	0.000195	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	9.39e-06	0.000194	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS1—type 2 diabetes mellitus	9.31e-06	0.000193	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	9.21e-06	0.000191	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	8.92e-06	0.000185	CbGpPWpGaD
Nepafenac—PTGS2—Disease—INS—type 2 diabetes mellitus	8.92e-06	0.000185	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	8.77e-06	0.000182	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	8.74e-06	0.000181	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	8.64e-06	0.000179	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	8.62e-06	0.000179	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT2—type 2 diabetes mellitus	8.62e-06	0.000179	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.25e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	8.25e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	8.19e-06	0.00017	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	7.82e-06	0.000162	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—type 2 diabetes mellitus	7.82e-06	0.000162	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	7.61e-06	0.000158	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	7.54e-06	0.000156	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.47e-06	0.000155	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	6.85e-06	0.000142	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.55e-06	0.000136	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.55e-06	0.000136	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SRC—type 2 diabetes mellitus	5.78e-06	0.00012	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	5.17e-06	0.000107	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—type 2 diabetes mellitus	5.07e-06	0.000105	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—type 2 diabetes mellitus	3.9e-06	8.07e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	3.79e-06	7.85e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.59e-06	7.45e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.01e-06	6.24e-05	CbGpPWpGaD
